Elekta signs agreement to sell stake in Motala Verkstad AB
Stockholm, Sweden, December 15, 2010
Elekta has signed an agreement to sell its 49 percent stake in Motala Verkstad AB. The buyer is Qeep Group.
Motala Verkstad supplies a subsystem of the Leksell Gamma Knife ® and is also responsible for coordinating transportation of subsystems to Elekta’s customers. In order to develop the business in Motala Verkstad, Elekta has been looking for a stable majority owner.
Qeep Ventures, part of Qeep Group, has worked closely with Motala Verkstad since its acquisition of Motala Train. Following the acquisition, Qeep Ventures has contributed to an active ownership and a very positive development of Motala Train.
Jonas Karlström, Vice President Service & Operations, Elekta Instrument AB, says: "Elekta has a long-term supplier agreement in place with Motala Verkstad. We are confident that Qeep Ventures will develop Motala Verkstad further to create a stable company. This will result in its growth and secure long-term continued production of the Leksell Gamma Knife subsystem."
The sales agreement is signed with the condition that minority shareholders do not wish to use their pre-sale or pre-emption right. The effect of Elekta’s sale of shares on Elekta’s result is estimated at about SEK 5 million.
# # #
For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, +46 70 778 6010, email: [email protected]
# # #
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 10.45 CET on December 15, 2010.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
About Qeep Ventures AB
Qeep Ventures, part of Qeep Group, consists of experienced entrepreneurs and capital owners with long experience of successful business building. The portfolio includes Qeep Consulting, Ceres, Lunicore, Student Power and Motala Train.